Anti-ADA2B/ ADRA2B/ ADRA2L1 monoclonal antibody

Anti-ADA2B/ ADRA2B/ ADRA2L1 antibody for FACS & in-vivo assay

Target products collectionGo to ADRA2B/ADRA2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T41580-Ab-1/ GM-Tg-hg-T41580-Ab-2Anti-Human ADRA2B monoclonal antibodyHuman
GM-Tg-rg-T41580-Ab-1/ GM-Tg-rg-T41580-Ab-2Anti-Rat ADRA2B monoclonal antibodyRat
GM-Tg-mg-T41580-Ab-1/ GM-Tg-mg-T41580-Ab-2Anti-Mouse ADRA2B monoclonal antibodyMouse
GM-Tg-cynog-T41580-Ab-1/ GM-Tg-cynog-T41580-Ab-2Anti-Cynomolgus/ Rhesus macaque ADRA2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T41580-Ab-1/ GM-Tg-felg-T41580-Ab-2Anti-Feline ADRA2B monoclonal antibodyFeline
GM-Tg-cang-T41580-Ab-1/ GM-Tg-cang-T41580-Ab-2Anti-Canine ADRA2B monoclonal antibodyCanine
GM-Tg-bovg-T41580-Ab-1/ GM-Tg-bovg-T41580-Ab-2Anti-Bovine ADRA2B monoclonal antibodyBovine
GM-Tg-equg-T41580-Ab-1/ GM-Tg-equg-T41580-Ab-2Anti-Equine ADRA2B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T41580-Ab-1/ GM-Tg-hg-T41580-Ab-2; GM-Tg-rg-T41580-Ab-1/ GM-Tg-rg-T41580-Ab-2;
GM-Tg-mg-T41580-Ab-1/ GM-Tg-mg-T41580-Ab-2; GM-Tg-cynog-T41580-Ab-1/ GM-Tg-cynog-T41580-Ab-2;
GM-Tg-felg-T41580-Ab-1/ GM-Tg-felg-T41580-Ab-2; GM-Tg-cang-T41580-Ab-1/ GM-Tg-cang-T41580-Ab-2;
GM-Tg-bovg-T41580-Ab-1/ GM-Tg-bovg-T41580-Ab-2; GM-Tg-equg-T41580-Ab-1/ GM-Tg-equg-T41580-Ab-2
Products NameAnti-ADRA2B monoclonal antibody
Formatmab
Target NameADRA2B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ADRA2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ADA2B/ ADRA2B/ ADRA2L1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP003709human ADRA2B Lentivirus particle
    ORF Viral VectorpGMLP003709human ADRA2B Lentivirus plasmid
    ORF Viral VectorpGMLPm004977mouse Adra2b Lentivirus plasmid
    ORF Viral VectorvGMLPm004977mouse Adra2b Lentivirus particle


    Target information

    Target IDGM-T41580
    Target NameADRA2B
    Gene ID151,11552,24174,694825,100855976,101090432,516422,100051684
    Gene Symbol and Synonymsa2b-AR,Adra-2b,ADRA2B,ADRA2L1,ADRA2RL1,adrab2,ADRARL1,alpha-2BAR,alpha2-C2,alpha2B,ALPHA2BAR,FAME2,[a]2B
    Uniprot AccessionP18089,P19328,O77700,O77721
    Uniprot Entry NameADA2B_HUMAN,ADA2B_RAT,ADA2B_BOVIN,ADA2B_HORSE
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000274286
    Target ClassificationN/A

    The target: ADRA2B, gene name: ADRA2B, also named as ADRA2L1, ADRA2RL1, ADRARL1, ALPHA2BAR, FAME2, alpha-2BAR. This intronless gene encodes a seven-pass transmembrane protein. This protein is a member of a subfamily of G protein-coupled receptors that regulate neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.